RxDoctor Payments Data

Benjamin Gilliland, MD

Family Medicine · Tupelo, MSNPI 1073967238

Payments from drug & device makers

$8,254in general payments, 2019–2025

Across 547 payments — averaging $15.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$984
  • Pfizer$944
  • Amgen$867
  • Lilly USA, LLC$757
  • AstraZeneca$688
  • Johnson & Johnson$571
  • plus $3K from 32 others

What the payments were for

  • Food & beverage$8,254100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,254 in reported general payments places this provider in the 90th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$557,014
Medicare patients
1,275
Services billed
20,754

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide117$186,697
EliquisApixaban201$161,296
FarxigaDapagliflozin Propanediol176$147,924
JardianceEmpagliflozin117$147,756
TrulicityDulaglutide16$37,679
ArexvyRsvpref3 Antigen/As01e/Pf109$33,885
XareltoRivaroxaban29$32,351
ShingrixVaricella-Zoster Ge/As01b/Pf143$31,568
MounjaroTirzepatide22$30,785
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$23,653
MyrbetriqMirabegron24$18,853
Breo ElliptaFluticasone/Vilanterol21$10,559
SymbicortBudesonide/Formoterol Fumarate30$7,462
Losartan Potassium709$6,604
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$6,471

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$243$186,697117 claims
PfizerEliquis$944$161,296201 claims
AstraZenecaFarxiga, Symbicort$688$155,386206 claims
Boehringer IngelheimJardiance$265$147,756117 claims
GSKArexvy, Shingrix, Trelegy Ellipta, Breo Ellipta, Anoro Ellipta$294$104,827312 claims
Lilly USA, LLCTrulicity, Mounjaro$757$68,46338 claims
Johnson & JohnsonXarelto$571$32,35129 claims
Astellas Pharma US IncMyrbetriq$283$18,85324 claims
AbbVieSynthroid$984$5,94977 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →